Cytokine testing and challenges for diagnostic and clinical monitoring use - 05/02/25
Doi : 10.1016/j.jaci.2024.11.025
Vijaya Knight, MBBS, PhD a, b, ⁎ 
, Lusia Sepiashvili, PhD c, d, e
, Lusia Sepiashvili, PhD c, d, e a Department of Pediatrics, Section of Allergy and Immunology, University of Colorado School of Medicine, Aurora, Colo
b Children’s Hospital, Colorado, Aurora, Colo
c Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
d Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
e Sickkids Research Institute, Toronto, Ontario, Canada
∗Corresponding author: Vijaya Knight, MBBS, PhD, Department of Pediatrics, Section of Allergy and Immunology, University of Colorado School of Medicine, Children’s Hospital Colorado, 13123 E 16th Ave, Aurora, CO 80045.Department of PediatricsSection of Allergy and ImmunologyUniversity of Colorado School of MedicineChildren’s Hospital Colorado13123 E 16th AveAuroraCO80045
Key words : Cytokine, immunoassays, biologics, IL-6, siltuximab, emapalumab, anticytokine autoantibodies
Le texte complet de cet article est disponible en PDF.
Plan
© 2024
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 155 - N° 2
P. 410-413 - février 2025 Retour au numéro
Article précédent
- Implementation of the esophageal string test in clinical practice and research
- Shauna Schroeder, Cindy S. Bauer, Benjamin L. Wright
- Imaging eosinophil secretory granules: From storage containers to active, immune responder organelles
- Rossana C.N. Melo, Marc E. Rothenberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?